Full name
OLIDENT POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ DEPOT SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
20.59.Z - Manufacture of other chemical products, not elsewhere classified
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.90.Z - Non-specialized wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | -0,1 | 1,2 | 1693 |
Gross profit (loss) | 0,2 | -0,1 | 1,2 | 1668,7 |
EBITDA | 0,2 | -0,1 | 1,2 | 2499,8 |
Short time liabilities | 1 | 0,7 | 0,6 | -15,5 |
Other operating costs | 0 | 0 | 0 | -100 |
Equity capital | 0,1 | 0 | 1,1 | 2298,6 |
Operating profit (EBIT) | 0,2 | -0,1 | 1,2 | 1668,7 |
Assets | 1,2 | 0,8 | 1,7 | 129,9 |
Net profit (loss) | 0,2 | -0,1 | 1,1 | 1532,2 |
Cash | 0,4 | 0,1 | 0,4 | 257,2 |
Net income from sale | 5,6 | 5,2 | 5,4 | 4,1 |
Liabilities and provisions for liabilities | 1 | 0,7 | 0,6 | -15,5 |
Working assets | 1,1 | 0,8 | 1,7 | 129,9 |
Other income costs | 0 | 0 | 0 | -100 |
Depreciation | 0 | 0 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | 145,3 | -160,5 | 95,8 | 256,3 |
Equity capital to total assets | 10,7 | 6,3 | 65,6 | 59,3 |
Gross profit margin | 3,4 | -1,5 | 22,3 | 23,8 |
EBITDA Margin | 3,5 | -1 | 22,3 | 23,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 67 | 50 | 41 | -9 |
Current financial liquidity indicator | 1.074819564819336 | 1.0670415163040161 | 2.903043508529663 | 1,8 |
Net dept to EBITDA | -1.535589575767517 | 1.2069971561431885 | -0.3116471767425537 | -1,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane